Main

type

0 (not classified)

status

21 (imported old-v2, waiting for another import)

review version

0

cleanup version

0

pending deletion

0 (-)

created at

2025-12-01 22:38:50

updated at

2025-12-01 22:38:51

Address

url

https://www.abbvie.ch/en/science/publication-of-clinical-trials/upadacitinib-rinvoq.html

url length

88

url crc

13171

url crc32

3356242803

location type

1 (url matches target location, page_location is empty)

canonical status

10 (verified canonical url)

canonical page id

3064159117

Source

domain id

2495993

domain tld

756

domain parts

0

originating warc id

-

originating url

https://data.commoncrawl.org/crawl-data/CC-MAIN-2025-33/segments/1754151279919.59/warc/CC-MAIN-20250806171101-20250806201101-00844.warc.gz

source type

11 (CommonCrawl)

Server response

server ip

172.64.149.50

Publication date

2025-08-06 18:27:47

Fetch attempts

0

Original html size

95003

Normalized and saved size

92007

Content

title

Publication of Clinical Trials - Upadacitinib: Rinvoq

excerpt

content

We publish synopses from Clinical Study Reports (CSR) to supplement the public information. This provides patients and healthcare providers with the results of our clinical trials and the evidence used to authorise Rinvoq. Here you can find the CSR synopses after Rinvoq was granted marketing authorisation in Switzerland and the USA.

author

updated

2025-12-09 04:05:52

Text analysis

block type

0

extracted fields

104

extracted bits

title
full content
content was extracted heuristically

detected location

0

detected language

1 (English)

category id

-

index version

1

paywall score

0

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

279

text words

51

text unique words

40

text lines

1

text sentences

3

text paragraphs

1

text words per sentence

17

text matched phrases

0

text matched dictionaries

0